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Abstract  
 
Objective: Thalassemia is one of the most frequent monogenic disorders, leading to impairment in the maturation and 
survival of red blood cells. The question examined here is whether, and if so, to what extent, people with beta-
thalassemia might also be impaired in their cognitive functioning. Previous results in adults with beta-thalassemia 
showed cognitive impairment when compared to healthy controls. However, length of education was never taken into 
consideration as a possible confounder. Accordingly, the aim of the present study was to assess people with minor beta-
thalassemia and compare them to healthy controls, while controlling for length of education. 
Method: A total of 25 adults (mean age: 29.36 years; 56% females) with beta-thalassemia and 25 healthy controls 
(mean age: 27.84 years; 72% females) took part in this cross-sectional study. They underwent cognitive testing 
(executive functions, attention, working memory), and their haemoglobin levels were assessed. 
Results: Cognitive performance did not significantly differ between patients with minor beta-thalassemia and healthy 
controls. Irrespective of group, higher cognitive performance was strongly associated with time spent in education. No 
gender differences were observed. 
Conclusion: Compared to healthy controls, cognitive performance was not impaired among patients with minor beta-
thalassemia when length of education was introduced as a further co-variate. In both patients with minor beta-
thalassemia and healthy controls, higher cognitive performance was associated with time spent for education. Health 
professionals should inform patients with minor beta-thalassemia that cognitive performance is related to the length of 
education and not to the health status of minor beta-thalassemia per se. 
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Thalassemia is a monogenic disorder, which passes 
from parents to their offspring by autosomal recessive 
inheritance (1, 2). Further, thalassemia is a 
heterogeneous group of abnormalities in haemoglobin 
biosynthesis, which is particularly prevalent in 
Mediterranian area (Italy, Cyprus, Greece, Sicily), the 
Middle East (Iran, Turkey, Syria), and Southeast Asia, 
an area thus extending from southwest Europe to the Far 
East. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The main defect is not in the molecular structure of 
haemoglobin; rather, the abnormality is in the 
quantitative synthesis of each alpha and beta chain, 
resulting in an unbalanced synthesis of globin chains and 
in the precipitation of additional chains, which 
ultimately causes impairment in the maturation and 
survival of red blood cells and of the red blood cell lysis 
(1-3(. 
 
 
 
 
 
 
 
 
 
 
Beta-thalassemia is also found in vast areas of Central 
Africa 4 . 
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Thalassemia is one of the most common genetic 
disorders in the world, with approximately 200 million 
sufferers. About 15% of African-Americans are 
thalassemia carriers. The trait of Alpha thalassemia 
(minor) is prevalent in 3% of the Americans and in 1%-
15% of the Mediterranean population (3). Each year, 
more than 4 million children in the world are born with 
genetic disorders, and thalassemia is one of the most 
prevalent type of these disorders (5, 6). Transfusion and 
iron chelation are the first-line treatments for this 
disorder, while efforts are also now being made to treat 
thalassemia via gene therapy (7). 
Given the high prevalence of thalassemia and the 
challenges posed by its treatment, the question arises 
whether, and if so to what extent, minor beta-thalassemia 
might be associated with poorer cognitive functioning. 
Previous works have compared children and adults with 
beta-thalassemia to gender- and age-matched controls. 
For example, Shehata et al. (8) compared cognitive 
functions and thalassemia biomarkers, such as ferritin, 
serum transferrin receptor, and nitric oxide levels, in 40 
children with thalassemia and 40 healthy controls. As 
expected, significantly higher levels of ferritin and 
serum transferrin receptors with decreased nitric oxide 
were detected among children with beta-thalassemia. 
Cognitive functions did not differ between children with 
and without thalassemia; however, there were significant 
correlations between serum transferrin receptors and 
nitric oxide levels on the one hand and cognitive 
functioning on the other. In contrast, Duman et al. (9) 
found a significant reduction in the executive 
performance and verbal IQ of children with major beta-
thalassemia when compared to healthy controls. 
However, Karimi et al. (10) compared the IQ (Raven’s 
Test) of children with major beta-thalassemia and of 
healthy children, but found no difference . 
As regards to adults, Nevruz et al. (11) showed that the 
cognitive functioning of 32 patients with beta-
thalassemia was poorer than that of controls. Zangiabadi 
et al. (12) compared the cognitive functioning of 30 
patients with beta-thalassemia with that of gender- and 
age-matched controls and showed that the former had 
lower performances on the vocabulary and arithmetic 
subtests of the Wechsler Adult Intelligence Scale 
(WAIS). Monastero et al. (13) investigated cognitive 
performance decline and focused on abstract reasoning, 
attention, executive functions, language, 
constructional/visuospatial skills, and memory. Their 
sample consisted of 46 patients with (major) beta-
thalassemia and 46 healthy controls. The patient group 
had lower scores for cognitive performance than the 
healthy controls. Poorer cognitive performance was also 
associated with a shorter time interval between the onset 
of blood transfusions, while the onset of chelating 
treatment correlated with performances on tests 
assessing abstract reasoning, attention, 
constructional/visuospatial skills, and memory. 
However, cognitive performance and haemoglobin 
levels were unrelated (13). 
To summarize, evidence on the association between 
beta-thalassemia and cognitive performance is not 
consistent. While no such association has been found 
among children, research on adults has indicated an 
association between beta-thalassemia status and 
cognitive performance, but no association has been 
observed between haemoglobin levels and cognitive 
performance . 
Strangely, to our knowledge, no study has yet considered 
gender and educational level as factors. Given the 
extensive body of research on sex differences in 
physiological and psychological characteristics, such 
differences may also be observable as regards to beta-
thalassemia and cognitive performance. Research shows 
that the extent and level of education impacts on later 
cognitive performance (14, 15). Thus, it is likely that 
current cognitive performance reflects previously 
accumulated exposure to education.  
The following hypotheses and one research question 
were formulated. First, we anticipated that haemoglobin 
levels would be higher in people with minor beta-
thalassemia than in healthy controls. Second, following 
previous results (11-13), we expected poorer cognitive 
performance in adults with minor beta-thalassemia than 
in healthy controls. Third, following Shehata et al., 8 we 
expected that poorer cognitive performance and higher 
beta-thalassemia biomarkers would be associated. 
Fourth, following others (14, 15), we expected that 
current cognitive performance would be associated with 
years of education completed. Next, we treated as 
exploratory whether and to what extent gender 
differences might be observed. 
We believe that this study has the potential to shed light 
on the complex association between minor beta-
thalassemia and cognitive performance, while 
considering beta-thalassemia-related biomarkers along 
with possible confounders such as gender and education. 
 
Materials and Methods 
Procedure 
Eligible patients with minor beta-thalassemia and 
healthy controls were approached to participate in the 
study. All participants were informed about the aims of 
the study and the anonymous data handling. Then, they 
signed a written informed consent. Participants 
completed questionnaires on sociodemographic and 
health-related information. Next, they underwent 
cognitive testing (cognitive flexibility; performance 
attention; information processing; working memory). 
Blood samples were taken between 8 am and 9 am. The 
study was approved by the Review Board of Hamadan 
University of Medical Sciences (HUMS; Hamadan, Iran) 
and performed in accordance with the rules of the 
Declaration of Helsinki and its later amendments. 
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Samples 
Adults with minor beta-thalassemia: 
Individuals with known minor beta-thalassemia 
undergoing risk-analysis for marriage were asked to 
participate in the study. A total of 41 people was 
approached and 25 (61%) agreed to participate. 
Inclusion criteria were as follow: (a) age 18-40 years; (b) 
willing and able to follow the study protocol; (c) written 
informed consent; (d) known and medically confirmed 
minor beta-thalassemia. Exclusion criteria were as 
follow: (a) known and confirmed mental impairments, 
such as psychiatric disorders (eg, major depressive 
disorders, bipolar disorders, substance use disorders, 
neurodegenerative disorders, autism spectrum disorders, 
schizophrenia), or mental retardation; (b) acute 
suicidality; (c). Illiteracy.  
 
Healthy Controls 
Healthy controls were recruited from hospital staff 
members and their adult relatives. Inclusion criteria were 
as follow: (a) age 18- 40 years; (b) willing and able to 
follow the study protocol; (c) written informed consent. 
Exclusion criteria were as follow: (a) known and 
medically confirmed minor beta-thalassemia; (b) Current 
psychiatric issues (eg, major depressive disorders, 
bipolar disorders, substance use disorders, 
neurodegenerative disorders, autism spectrum disorders, 
schizophrenia, and acute suicidality); (c) Current 
somatic issues.  
 
Tools  
Sociodemographic Information 
Participants completed a questionnaire providing details 
of age, gender, and education.  
 
Assessing Executive Performance with the Wisconsin 
Card Sorting Test 
As described elsewhere(16), the Wisconsin card sorting 
test (WCST) is a neuropsychological test to assess 
cognitive flexibility or, more specifically, the ability to 
display flexibility in the face of changing schedules of 
reinforcement (17, 18). First, a number of stimulus cards 
are presented to the participant. Next, the experimenter 
tells the respondent to match the cards and tells her/him 
whether a particular match is right or wrong. The 
respondent should gain insight into the hidden pattern 
(rule) and match the cards accordingly. Following an 
algorithm unknown to the respondent, the hidden pattern 
(rule) is changed, and he or she needs to discover the 
new hidden pattern (rule). From the perspective of 
cognitive psychology, three cognitive tasks have to be 
solved: first, gaining insight into the hidden pattern; 
second, building a cognitive representation of the hidden 
pattern; and third, shifting from this cognitive 
representation to a new insight into how to solve the now 
modified problem (eg, achieving freedom from 
functional fixation). The test takes approximately 12–20 
minutes to complete and generates a number of 
psychometric measures, including numbers, percentages, 
and percentiles of categories achieved, trials, errors, and 
perseverative errors.  
 
Assessing performance attention 
The digit span subtest of the Paced Auditory Serial 
Addition Test (PASAT) were used to assess 
performance attention.  
As outlined elsewhere (19), the PASAT (20, 21) is a test 
battery to assess auditory information processing speed 
and flexibility. Single digits are presented either every 3 
seconds (3-second PASAT) or every 2 seconds (2-
second PASAT), and the respondent must add each new 
digit to the one immediately prior to it. The test result is 
the number of correct sums given out of the 60 possible 
correct answers.  
 
Assessing Working Memory 
The Digit Span subtest of the Wechsler (Wechsler Adult 
Intelligence Scale) was used to test working memory. 
Briefly, in the Digit Span subtest one has to repeat a 
series of numbers in the same order given, backwards, or 
from lowest to highest. 
 
Haemoglobin Testing 
Electrophoresis was performed using automatic Interlab 
G26 by gel electrophoresis, along with a quantitative 
measurement of HbA2 by column chromatography using 
a bio-system kit. By combining these 2 methods, the 
exact amounts of HbA, HbA2, and HbF were determined 
to detect minor beta-thalassemia. 
 
Data Analysis 
A series of ANOVAs were computed with the factors of 
gender (male vs. female) and group (minor beta-
thalassemia vs. healthy controls) and with cognitive 
tests, haemoglobin levels, and education (in years) as 
dependent variables. Next, a series of Pearson’s 
correlations were performed between cognitive tests, 
haemoglobin levels, and education, both for the entire 
group and separately for patients with minor beta-
thalassemia and healthy controls. The nominal level of 
significance was set at alpha  0.05. Data analysis was 
performed with SPSS® 25.0 (IBM Corporation, Armonk 
NY, USA) for Apple® Mac®. 
 
Results 
All descriptive and inferential statistical indices are 
reported in Tables 1 to 3. Accordingly, these statistics 
are not repeated in the text.  
 
Sociodemographic Information 
Patients and healthy controls did not differ as regards to 
gender distribution, age, or years of education. 
 
Haemoglobin Levels 
Haemoglobin levels were significantly higher in the 
minor beta-thalassemia group than in the healthy 
controls, irrespective of gender (Table 1). 
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Table 1. Descriptive and Inferential Statistical Overview of Psychosocial and Blood-Related Information for People with and without Minor 
Beta-Thalassemia and for Gender 
 
 Groups   Statistics 
 
With Minor Beta-
Thalassemia 
 
Healthy Controls  
 Females Males  Females Males  
N 14 11  18 7 X
2
(N= 50, df = 1) = 1.39, p = 0.24 
 M (SD) M (SD)  M (SD) M (SD)  
Age (years) 29.57 (4.21) 29.09 (5.32) 
 
27.67 (4.72) 
28.29 
(5.25) 
Group: F(1, 45) = 0.88, p = 0.36 
Gender: F(1, 45)= 0.01, p = 0.96 
Group x Gender: F(1, 45)= 0.14, p = 0.71 
Years of 
education 
15.21 (2.60) 14.70 (2.50) 
 
14.83 (3.24) 
13.57 
(1.99) 
Group: F(1, 45) = 0.88, p = 0.38 
Gender: F(1, 45)= 1.11, p = 0.29 
Group x Gender: F(1, 45)= 0.99, p = 0.66 
HbA1c 5.71 (0.55) 6.02 (0.41) 
 
3.98 (1.26) 4.56 (1.60) 
Group: F(1, 45) = 34.59, p = 0.001 
Gender: F(1, 45)= 2.56, p = 0.19 
Group x Gender: F(1, 45)= 1.18, p = 0.28 
 
 
Table 2. Descriptive Overview of Cognitive Performance, Separately for Those with and without Minor Beta-Thalassemia and for Males and 
Females 
   Groups 
 Minor Beta-Thalassemia Healthy Controls 
 Females Males Females Males 
N 14 11 18 7 
 M (SD) M (SD) M (SD) M (SD) 
WCST     
Classification 2.36 (2.02) 1.36 (1.12) 2.39 (2.40) 2.00 (1.63) 
Perseveration 9.93 (7.33) 9.09 (9.63) 10.28 (7.03) 10.86 (6.04) 
Conceptual 2.07 (2.70) 2.00 (2.72) 2.33 (3.01) 1.86 (2.85) 
PASAT     
3 seconds 35.93 (15.61) 39.45 (11.26) 36.89 (12.79) 39.57 (11.72) 
2 seconds 25.5 (11.27) 31.36 (9.04) 28.00 (11.86) 25.86 (12.27) 
WAIS     
Coding 55.36 (14.87) 44.55 (15.74) 54.22 (15.31) 44.43 (6.32) 
Forward 5.14 (2.28) 6.09 (2.91) 4.39 (2.00) 4.28 (1.80) 
Backward 6.29 (1.90) 6.18 (2.40) 7.70 (2.78) 7.57 (1.99) 
Notes: WCST = Wisconsin Card Sort Test; PASAT = Paced Auditory Serial Addition Test; WAIS = Wechsler Adult Intelligence 
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Table 3. Inferential Statistical Indices of Cognitive Performance with the Factors Group (with and 
without Minor Beta-Thalassemia), Gender, and Group by Gender Interaction 
 
  Factors  
 Group Sex Group x Sex Interaction 
 F partial eta
2
 F Partial eta
2
 F Partial eta
2
 
WCST    
Classification 0.32 0.07 1.35 0.03 0.26 0.01 
Perseveration 0.21 0.01 0.00 0.00 0.10 0.00 
Conceptual 0.01 0.00 0.01 0.00 0.06 0.00 
PASAT    
3 seconds 0.02 0.00 0.61 0.00 0.01 0.00 
2 seconds 0.20 0.00 0.31 0.00 1.42 0.02 
WAIS    
Coding 0.02 0.00 3.56 0.11 0.01 0.00 
Forward 3.48 0.07 0.38 0.01 0.59 0.01 
Backward 3.92 0.08 0.03 0.00 0.00 0.00 
 
 
Table 4. Correlations of Age, Educational Level, and Haemoglobin Levels with Cognitive Performances 
 
 Age Educational Level Haemoglobin Level 
WCST    
Classification -0.24
(
*
)
 0.43** -0.06 
Perseveration 0.27 -0.40** -0.05 
Conceptual -0.24
(
*
)
 0.29* -0.06 
PASAT    
3 seconds -0.18 0.54*** 0.00 
2 seconds -0.14 0.52*** 0.08 
WAIS    
Coding -0.39* 0.66*** 0.06 
Forward -0.03 0.38** 0.08 
Backward -0.25
(
*
)
 0.20* 0.12 
 
Notes: WCST = Wisconsin Card Sort Test; PASAT = Paced Auditory Serial Addition Test; WAIS = Wechsler Adult Intelligence; 
(
*
) 
= p 
< 0.10; * = p < 0.05, ** = p < 0.01; *** = p < 0.001. 
 
No significant differences were found in cognitive 
performances between the groups, genders, or as a 
function of the group by gender interaction (Tables 2 
and 3). 
 
Correlations among Cognitive Performance, Age, 
Haemoglobin, and Educational level 
Table 4 demonstrates the intercorrelations among the 
dimensions of cognitive performance, age, haemoglobin, 
and educational level.  
Cognitive performance was unrelated to age or 
haemoglobin levels, though it was significantly related 
to years of education, both across the sample as a whole 
(Table 4) and separately for those with beta-thalassemia 
and healthy controls (data not shown).  
 
Discussion 
The key finding of this study was that patients with 
minor beta-thalassemia did not display impaired 
cognitive performance compared to healthy controls. 
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Furthermore, cognitive performance was unrelated to 
either hemoglobin levels or gender. Years of education 
were strongly associated with level of cognitive 
performance . 
Four hypotheses and 1research question were 
formulated. 
Our first hypothesis was that individuals with minor 
beta-thalassemia would have higher hemoglobin levels 
than healthy controls, and this was confirmed. While the 
result is unsurprising, it helped us ascertain that people 
with minor beta-thalassemia could be clearly 
distinguished from healthy controls at a biological level . 
Our second hypothesis was that individuals with minor 
beta-thalassemia would perform more poorly on 
cognitive tasks than healthy controls. This hypothesis 
was not supported. Thus, the present results are at odds 
with previously published findings for adults (11-13). 
However, our findings are consistent with evidence from 
studies of children (8, 10), which revealed no deficits in 
cognitive functioning associated with beta-thalassemia. 
We do not have the data that might provide a deeper 
understanding of the lack of difference we found, 
although in previous studies (11-13) a straightforward 
psychophysiological rationale was missing. Nevruz et al. 
(11) assessed cognitive performance with an auditory 
test, while they were not interested in the test 
performance. However, in the P300 potentials, 
Zangiabadi et al. (12) found lower performances in 
patients with minor beta thalassemia in subtests of 
arithmetic and vocabulary and picture completion, while 
on the non-verbal scale, they found no significant 
difference between the two groups. However, 
Zangiabadi et al. (12) and Monastero et al. (22) did not 
control for length of education. 
Our third hypothesis was that a poorer cognitive 
performance would be associated with higher beta-
thalassemia biomarkers, but again this hypothesis was 
not supported, and our findings contrast with evidence 
from previous research on children (8). On the other 
hand, the present findings confirm what Monastero et al. 
(13) observed among adults. Overall, the present results 
indicate that the associations between minor beta-
thalassemia and its underlying blood-related and 
physiological processes and cognitive performance are 
not straightforward . 
Our fourth hypothesis was that current cognitive 
performance would be associated with length of time 
spent in education, and this hypothesis was strongly 
supported. We followed previous research (14, 15) 
showing that length of education has an impact on 
higher cognitive performance in later years of adulthood. 
While we have no direct evidence for this kind of causal 
relationship in the present study, it does seem possible 
that a more extended academic education could lead to 
greater cognitive flexibility, better knowledge, and 
superior performance later on . 
In response to the exploratory question, we found that 
gender was not a confounder, as cognitive performance, 
haemoglobin levels, duration of academic education did 
not systematically vary as a function of gender. 
 
Limitations 
Despite the potential interest of the findings, there are 
some limitations that should be acknowledged. First, the 
sample size was rather small, although the means and 
standard deviations shown in Table 2 indicate that even 
with larger sample sizes significant differences would 
not have been found. Second, we focused on executive 
functions, performance attention, and working memory, 
while other domains of cognitive performance, such as 
problem solving, decision-making, language, and 
complex perception, might have yielded a different 
pattern of results. Third, it is possible that further 
unassessed latent variables might have biased 2 or more 
variables in the same or opposite direction. Accordingly, 
future studies might assess other cognitive, but also 
emotional domains, such as anxiety, coping, depression, 
and self-efficacy, as further possible targets. 
 
Conclusion 
Among a sample of adults with minor beta-thalassemia 
and compared to healthy controls, level of cognitive 
performance was related to length of education, but not 
to haemoglobin levels or gender. 
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